top of page
gradientForSurfBreak.png

Item List

Jun 17, 2025
Morningstar
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2

Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds.

Recent Posts

Portfolio Company

Carlsmed.png

Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinica ...

Businesswire

Apr 30, 2026

Portfolio Company

Carlsmed.png

Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectr ...

BioSpace

Apr 16, 2026

Portfolio Company

Carlsmed.png

The most innovative healthcare companies of 2026 ...

Fast Company

Mar 24, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page